FIELD: medicine.
SUBSTANCE: group of inventions can be used for treating fungal infection. That is ensured by administering a compound according to claim 1
or a pharmaceutically acceptable salt thereof in a dose of saturation or one or more maintenance doses of the compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein each of said doses is administered in an amount sufficient for treating fungal infection. Also provided are a dosage form for injection in single-dose or multi-dose containers in form of an aqueous solution or a lyophilized composition for reduction, comprising a compound of claim 1 or a pharmaceutically acceptable salt thereof, and an apparatus for injecting an aqueous solution of the compound of claim 1 or a pharmaceutically acceptable salt thereof, comprising container containing 0.05 to 10 ml of an aqueous solution comprising a compound of claim 1 or a pharmaceutically acceptable salt thereof, and a needle.
EFFECT: group of inventions enables effective treatment of a fungal infection with less frequent dosing ensured by the stability of the compound.
26 cl, 22 dwg, 14 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
DOSING MODES FOR ECHINOCANDINE CLASS COMPOUNDS | 2013 |
|
RU2639483C2 |
PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS | 2012 |
|
RU2640912C2 |
COMBINED THERAPY FOR IMMUNE DISEASE TREATMENT | 2004 |
|
RU2329037C2 |
ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TAXANES AND METHODS FOR TREATMENT USING THEREOF | 1999 |
|
RU2236226C2 |
COMPOSITIONS AND METHODS FOR APOLIPOPROTEIN C-III (APOC3) GENE EXPRESSION INHIBITION | 2012 |
|
RU2631805C2 |
CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
FORMULATIONS FOR ORAL ADMINISTRATION OF DRUG PREPARATIONS AND RELATED METHODS | 2008 |
|
RU2485975C2 |
ORAL ADMINISTRATION OF UNSTABLE OR POORLY ABSORBED DRUGS | 2015 |
|
RU2746548C2 |
ANTIFUNGAL AGENTS | 2015 |
|
RU2727520C2 |
Authors
Dates
2020-04-21—Published
2013-03-14—Filed